|
FUNDC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.352220E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.395700E-03 |
| Normal-vs-Stage2 |
3.266400E-01 |
| Normal-vs-Stage3 |
6.992200E-01 |
| Normal-vs-Stage4 |
5.170000E-01 |
| Stage1-vs-Stage2 |
1.855570E-01 |
| Stage1-vs-Stage3 |
1.340170E-01 |
| Stage1-vs-Stage4 |
2.447800E-01 |
| Stage2-vs-Stage3 |
6.963600E-01 |
| Stage2-vs-Stage4 |
9.001400E-01 |
| Stage3-vs-Stage4 |
8.429800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.079100E-03 |
| Normal-vs-AfricanAmerican |
2.480800E-01 |
| Normal-vs-Asian |
2.387200E-01 |
| Caucasian-vs-AfricanAmerican |
2.195800E-01 |
| Caucasian-vs-Asian |
9.735100E-03 |
| AfricanAmerican-vs-Asian |
1.361760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.32439999999978E-05 |
| Normal-vs-Female |
6.704200E-02 |
| Male-vs-Female |
6.22701890051758E-12 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.342000E-01 |
| Normal-vs-Extreme_Weight |
1.210460E-04 |
| Normal-vs-Obese |
6.434500E-02 |
| Normal-vs-Extreme_Obese |
5.200000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.219200E-03 |
| Normal_Weight-vs-Obese |
1.603840E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.037000E-01 |
| Extreme_Weight-vs-Obese |
1.844850E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.560800E-01 |
| Obese-vs-Extreme_Obese |
5.638400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.527200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.506750E-01 |
| Normal-vs-Age(61-80Yrs) |
2.634600E-04 |
| Normal-vs-Age(81-100Yrs) |
3.290300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.181400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.458600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.570000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.363950E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.290400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.895200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.387100E-04 |
| Normal-VS-Type2 PRCC |
8.723800E-02 |
| Normal-VS-KIRP CIMP |
3.668000E-01 |
| Normal-VS-Unclassified PRCC |
4.584600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.002400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.297100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.958000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.829500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.319400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.470400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.975600E-02 |
| Normal-vs-N1 |
7.875800E-01 |
| Normal-vs-N2 |
9.123200E-01 |
| N0-vs-N1 |
1.031240E-01 |
| N0-vs-N2 |
4.023000E-01 |
| N1-vs-N2 |
8.520200E-01 |
|
|
